Vanesa Bernal-Monterde
Zaragoza, AR, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Left atrial appendage closure for atrial fibrillation patients at high risk of gastrointestinal bleeding. An evidence-based multidisciplinary review for gastroenterologists.
Journal: Revista espanola de enfermedades digestivas
Published: January 22, 2026
Hepatocellular carcinoma in non-cirrhotic liver: a prospective Spanish multicenter study.
Journal: Revista espanola de enfermedades digestivas
Published: December 18, 2025
Hypoxia in MASLD: a spatial determinant of the pathogenesis.
Journal: Trends in molecular medicine
Published: November 15, 2025
RECOMPENSATION FOLLOWING ALCOHOL-RELATED HEPATITIS IS ASSOCIATED WITH INCREASED SURVIVAL: RESULTS FROM A MULTICENTER STUDY.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: September 10, 2025
Recompensation Following Alcohol-Related Hepatitis Is Associated With Increased Survival: Results From a Multicenter Study.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: September 10, 2025
Obesity-Mediated Inflammation and Its Influence on Inflammatory Bowel Disease: Pathophysiology, Clinical Impact, and Therapeutic Implications.
Journal: Biomolecules
Published: June 22, 2025
Unveiling Drug-Induced Autoimmune-Like Hepatitis in Autoimmune Hepatitis Patients: A Multicenter Retrospective Study.
Journal: Alimentary pharmacology & therapeutics
Published: May 01, 2025
Defining Noninvasive Criteria for Indicating Drug Therapy in Metabolic Dysfunction-associated Steatotic Liver Disease in Clinical Practice.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: April 21, 2025
MASLD-Related Hepatocarcinoma: Special Features and Challenges.
Journal: Journal of clinical medicine
Published: May 16, 2024
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir.
Journal: Alimentary pharmacology & therapeutics
Published: February 09, 2024
Lipid Profile and Cardiovascular Risk Modification after Hepatitis C Virus Eradication.
Journal: Pathogens (Basel, Switzerland)
Published: February 05, 2024
Last Updated: 09/26/2026